Basic and Clinical Andrology

Call for Papers: Thematic Series on "Advancements in Male Contraception"

Male hormonal contraception has been an active area of research for almost 50 years. However, at present, there is still a gap in contraceptive options for couples, and more particularly, effective reversible contraceptives for men. 

This article collection further explores the most recent research documenting the advancements in male contraception.

Submission is open to everyone.

Featured article: Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide

Although recent progress in cancer treatment has increased patient survival and improved quality of life, reproductive side effects are still for concern. One way to decrease gonadal impairment is to use cytoprotectors. In testicular cancer, N-acetylcysteine (NAC) has the ability to counteract etoposide-induced toxicity rather than preventing the etoposide cytotoxic effects over sperm DNA, suggesting that the administration of NAC to cells formerly exposed to etoposide is preferable to its prophylactic use. This reinforces the idea that there might be a new NAC mechanism over DNA.

Society Affiliations

Basic and Clinical Andrology is the official journal of French Society of Andrology (SALF). Authors from SALF are entitled to a discounted article-processing charge of 1000 GBP which is payable upon editorial acceptance of their manuscript for publication. To facilitate this, SALF members should indicate their membership (in payment option number 3) when submitting a manuscript.

Basic and Clinical Andrology is affiliated with the French federation Centre d'Etude et de Conservation de Oeufs et du Sperme Humains (CECOS). Members of CECOS are entitled to a £250 discount on their article-processing charge which is payable upon editorial acceptance of their manuscript for publication. To facilitate this, eligible authors should indicate their membership (in payment option number 3) when submitting a manuscript.